Full-Body MRI: The Conversation Nobody's Having About What Comes Next
By Dr. Joana Costa , OM 48985 — Clinical Director, B-Life Clinic
Full-body MRI has become one of the most sought-after tools in longevity medicine, and there are good reasons for that. No ionising radiation, no contrast, and the ability to map multiple organs in a single session. In the case of B-Life Clinic's Full Body Scan, beyond oncological screening, it also quantifies visceral fat and iron, and provides musculoskeletal and vascular assessment. For someone between 35 and 45, healthy and asymptomatic, it can be a useful window for establishing a baseline against which to read the next two decades.
What hasn't yet entered the public conversation is what happens afterwards.
The scientific evidence is clear: no major medical society recommends this exam as routine screening in asymptomatic populations without specific risk factors.
The FDA states there is no evidence that it produces more benefit than harm in this context. Studies show that between 37 and 95 per cent of healthy individuals present some detected anomaly — the vast majority benign — and the detection rate for clinically relevant neoplasms falls below 2 per cent. No controlled trial has demonstrated a reduction in mortality in average-risk populations.
This doesn't mean the exam is useless. It means that, without clinical framing, it is like receiving a detailed map of a city you have never visited — full of information, with no indication of where to go. The report arrives, findings accumulate, and anyone reading it alone cannot distinguish what requires action from what can be safely ignored.
That is why at B-Life we have designed a protocol in which the scan is only one of the pieces. There is a prior consultation to stratify risk and align expectations, targeted ultrasound studies in parallel when relevant, and a personalised clinical report — developed with Dr. Gustavo Luersen (OM 63163) — that delivers the translation that matters: what deserves attention now, what to monitor, what can be safely ignored.
After this report-back, each person is followed by a preventive medicine physician who translates the results into a concrete action plan: what to treat, what to monitor, and how often.
The future of longevity medicine is not in running more tests. It is in running the right tests, with the right people to interpret them.
Without that translation, the most sophisticated scan in the world remains just an image.
